Financial results - FARMACIILE EXMED S.R.L.

Financial Summary - Farmaciile Exmed S.r.l.
Unique identification code: 43606958
Registration number: J34/44/2021
Nace: 4773
Sales - Ron
1.965.358
Net Profit - Ron
24.577
Employee
4
The most important financial indicators for the company Farmaciile Exmed S.r.l. - Unique Identification Number 43606958: sales in 2024 was 1.965.358 euro, registering a net profit of 24.577 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Farmaciile Exmed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - 22.682 140.173 184.750 1.965.358
Total Income - EUR - - - - - - 22.682 140.174 184.751 1.965.365
Total Expenses - EUR - - - - - - 47.644 197.684 195.817 1.935.081
Gross Profit/Loss - EUR - - - - - - -24.961 -57.510 -11.066 30.284
Net Profit/Loss - EUR - - - - - - -25.189 -58.913 -12.975 24.577
Employees - - - - - - 5 3 3 4
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 115.1%, from 184.750 euro in the year 2023, to 1.965.358 euro in 2024. The Net Profit increased by 24.577 euro, from 0 euro in 2023, to 24.577 in the last year.

Check the financial reports for the company - Farmaciile Exmed S.r.l.

Rating financiar

Financial Rating -
Farmaciile Exmed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Farmaciile Exmed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Farmaciile Exmed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Farmaciile Exmed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Farmaciile Exmed S.r.l. - CUI 43606958

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - 55.059 66.276 63.731 314.186
Current Assets - - - - - - 135.646 150.513 158.331 809.880
Inventories - - - - - - 100.784 85.881 87.735 419.946
Receivables - - - - - - 32.182 62.832 65.036 367.747
Cash - - - - - - 2.680 1.800 5.560 22.187
Shareholders Funds - - - - - - -25.148 -84.140 -96.859 -454.538
Social Capital - - - - - - 40 41 40 200
Debts - - - - - - 215.975 301.004 318.991 1.579.119
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 1 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 809.880 euro in 2024 which includes Inventories of 419.946 euro, Receivables of 367.747 euro and cash availability of 22.187 euro.
The company's Equity was valued at -454.538 euro, while total Liabilities amounted to 1.579.119 euro. Equity increased by 24.577 euro, from -96.859 euro in 2023, to -454.538 in 2024.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Farmaciile Exmed S.r.l.

Comments - Farmaciile Exmed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.